PT1448246E - Aparelho com revestimento homogeneo com propriedades osteoindutoras e osteocondutoras - Google Patents

Aparelho com revestimento homogeneo com propriedades osteoindutoras e osteocondutoras

Info

Publication number
PT1448246E
PT1448246E PT02803343T PT02803343T PT1448246E PT 1448246 E PT1448246 E PT 1448246E PT 02803343 T PT02803343 T PT 02803343T PT 02803343 T PT02803343 T PT 02803343T PT 1448246 E PT1448246 E PT 1448246E
Authority
PT
Portugal
Prior art keywords
relates
osteoinductive
properties
osteoconductor
osteoinduction
Prior art date
Application number
PT02803343T
Other languages
English (en)
Inventor
Ulrich Kohnert
Klaus Hellerbrand
Poehling Sylke
Happersberger Peter
Original Assignee
Scil Technology Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1448246(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scil Technology Gmbh filed Critical Scil Technology Gmbh
Publication of PT1448246E publication Critical patent/PT1448246E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Apparatuses And Processes For Manufacturing Resistors (AREA)
  • Dental Preparations (AREA)
  • Permanent Magnet Type Synchronous Machine (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT02803343T 2001-11-19 2002-03-27 Aparelho com revestimento homogeneo com propriedades osteoindutoras e osteocondutoras PT1448246E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01127573 2001-11-19

Publications (1)

Publication Number Publication Date
PT1448246E true PT1448246E (pt) 2005-11-30

Family

ID=8179288

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02803343T PT1448246E (pt) 2001-11-19 2002-03-27 Aparelho com revestimento homogeneo com propriedades osteoindutoras e osteocondutoras

Country Status (16)

Country Link
US (2) US8546334B2 (pt)
EP (1) EP1448246B2 (pt)
JP (2) JP4473576B2 (pt)
CN (1) CN100425285C (pt)
AT (1) ATE303169T1 (pt)
AU (1) AU2002308204B9 (pt)
BR (1) BR0214275A (pt)
CA (1) CA2466947C (pt)
CY (1) CY1105664T1 (pt)
DE (1) DE60205937T3 (pt)
DK (1) DK1448246T4 (pt)
ES (1) ES2247423T5 (pt)
HK (1) HK1071315A1 (pt)
PT (1) PT1448246E (pt)
SI (1) SI1448246T2 (pt)
WO (1) WO2003043673A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1462126A1 (en) * 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Improved Osteoinductive Materials
DE602005022998D1 (de) * 2004-03-10 2010-09-30 Scil Technology Gmbh Überzogene implantate, ihre herstellung und verwendung davon
EP1604694A1 (en) * 2004-06-09 2005-12-14 Scil Technology GmbH Composite device having osteoinductive and osteoconductive properties
US20100112028A1 (en) * 2004-06-09 2010-05-06 Klaus Hellerbrand Composite material for use as protein carrier
EP1604693A1 (en) 2004-06-09 2005-12-14 Scil Technology GmbH In situ forming scaffold, its manufacturing and use
US20060286171A1 (en) * 2005-06-17 2006-12-21 Tianhong Zhou Bone morphogenetic protein formulations
WO2007068489A2 (en) * 2005-12-14 2007-06-21 Scil Technology Gmbh A moldable biomaterial for bone regeneration
US20070299520A1 (en) * 2006-06-26 2007-12-27 Warsaw Orthopedic, Inc. Surface treatment of implantable devices
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
DE102006060958A1 (de) 2006-12-20 2008-06-26 Jennissen, Herbert P., Prof. Dr. Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
US20080221681A1 (en) * 2007-03-09 2008-09-11 Warsaw Orthopedic, Inc. Methods for Improving Fatigue Performance of Implants With Osteointegrating Coatings
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
EP2187932B1 (en) * 2007-08-07 2015-01-28 DePuy Synthes Products, LLC Protein formulations comprising gdf-5 in aqueous acidic solution
US20090061002A1 (en) * 2007-09-05 2009-03-05 Venbrocks Rudolf A Calcium phospate based delivery of growth and differentiation factors to compromised bone
DE102007051914A1 (de) * 2007-10-29 2009-05-07 Herbert Prof. Dr. Jennissen Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
CN102026619A (zh) * 2008-04-14 2011-04-20 先进科技及再生医学有限责任公司 液体缓冲的gdf-5制剂
US20110059149A1 (en) * 2008-06-16 2011-03-10 Little Marisa A Process for depositing calcium phosphate therapeutic coatings with different release rates and a prosthesis coated via the process
PL2435102T3 (pl) 2009-05-28 2021-01-11 Addbio Ab Wielowarstwowe folie białkowe, sposoby ich wytwarzania, urządzenia do podawania leku oraz implanty biomedyczne wykorzystujące folie
AU2011284657B2 (en) * 2010-07-30 2013-11-14 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Drug delivery devices and growth factor formulations for accelerated wound healing
WO2012093939A1 (en) 2011-01-05 2012-07-12 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Particles comprising calcium phosphate and use thereof
KR20210066006A (ko) * 2018-10-12 2021-06-04 세러댑티브, 인크. 베타-인산삼칼슘 결합 서열을 포함하는 폴리펩티드 및 이의 용도
EP3682931A1 (en) * 2019-01-21 2020-07-22 Universitätsklinikum Hamburg-Eppendorf Thoracic catheter

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329128A1 (de) 1983-08-11 1985-02-28 Bayer Ag, 5090 Leverkusen 3-cycloalkyl-1-(1,3-dioxan-5-yl)-2-(1,2,4-triazol-1-yl)-propan-1-one und -propan-1-ole
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US5366875A (en) 1986-07-01 1994-11-22 Genetics Institute, Inc. Methods for producing BMP-7 proteins
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5187076A (en) 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
WO1990011366A1 (en) 1989-03-28 1990-10-04 Genetics Institute, Inc. Osteoinductive compositions
US5459047A (en) 1986-07-01 1995-10-17 Genetics Institute, Inc. BMP-6 proteins
US5543394A (en) 1986-07-01 1996-08-06 Genetics Institute, Inc. Bone morphogenetic protein 5(BMP-5) compositions
US6432919B1 (en) 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US4877864A (en) 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
US5108922A (en) 1986-07-01 1992-04-28 Genetics Institute, Inc. DNA sequences encoding BMP-1 products
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US5631142A (en) 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US5939388A (en) 1986-07-01 1999-08-17 Rosen; Vicki A. Methods of administering BMP-5 compositions
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US6586388B2 (en) * 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US5324819A (en) * 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US5670336A (en) 1988-04-08 1997-09-23 Stryker Corporation Method for recombinant production of osteogenic protein
US4975526A (en) 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5011691A (en) * 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5344654A (en) * 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
CA1338663C (en) 1988-04-08 1996-10-22 Hermann Oppermann Biosynthetic osteogenic proteins and osteogenic devices containing them
US5162114A (en) 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5207710A (en) † 1988-09-29 1993-05-04 Collagen Corporation Method for improving implant fixation
US5108436A (en) 1988-09-29 1992-04-28 Collagen Corporation Implant fixation
US5258029A (en) 1988-09-29 1993-11-02 Collagen Corporation Method for improving implant fixation
US5158934A (en) 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
DE69032424T2 (de) 1989-10-17 1999-02-04 Stryker Corp., Kalamazoo, Mich. Osteogene vorrichtungen
DK27390D0 (da) 1990-02-02 1990-02-02 Troels Torp Andreassen Fremgangsmaade og apparat til administration af biologisk aktive stoffer
WO1992007073A1 (en) 1990-10-18 1992-04-30 Creative Biomolecules, Inc. Osteogenic peptides
US5656593A (en) 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US5972884A (en) 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5849686A (en) 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US6506729B1 (en) 1991-03-11 2003-01-14 Curis, Inc. Methods and compositions for the treatment and prevention of Parkinson's disease
US5652118A (en) 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6090776A (en) 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
WO1992015323A1 (en) 1991-03-11 1992-09-17 Creative Biomolecules, Inc. Protein-induced morphogenesis
US5674844A (en) 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US6211146B1 (en) 1991-03-11 2001-04-03 Curis, Inc. 60A protein-induced morphogenesis
US6395883B1 (en) 1991-03-11 2002-05-28 Curis, Inc. Soluble morphogenic protein complex compositions of matter
US5652337A (en) 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US6495513B1 (en) 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US6723698B2 (en) 1991-03-11 2004-04-20 Curis, Inc. Methods and compositions for the treatment of motor neuron injury and neuropathy
US6399569B1 (en) 1991-03-11 2002-06-04 Curis, Inc. Morphogen treatments for limiting proliferation of epithelial cells
CA2104678C (en) 1991-03-11 2002-05-14 Charles M. Cohen Protein-induced morphogenesis
US5707810A (en) 1991-03-11 1998-01-13 Creative Biomolecules, Inc. Method of diagnosing renal tissue damage or disease
US5650276A (en) 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
US6077823A (en) 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5563124A (en) 1991-04-22 1996-10-08 Intermedics Orthopedics/ Denver, Inc. Osteogenic product and process
US5290763A (en) 1991-04-22 1994-03-01 Intermedics Orthopedics/Denver, Inc. Osteoinductive protein mixtures and purification processes
US5177406A (en) 1991-04-29 1993-01-05 General Motors Corporation Active matrix vacuum fluorescent display with compensation for variable phosphor efficiency
DE4121043A1 (de) * 1991-06-26 1993-01-07 Merck Patent Gmbh Knochenersatzmaterial mit fgf
EP0523926A3 (en) 1991-07-15 1993-12-01 Smith & Nephew Richards Inc Prosthetic implants with bioabsorbable coating
ES2253736T3 (es) 1991-08-30 2006-06-01 Curis, Inc. Tratamiento para prevenir la perdida y/o aumentar la masa osea en transtornos metabolicos del hueso.
ATE192931T1 (de) 1991-08-30 2000-06-15 Creative Biomolecules Inc Morphogen-induzierte modulation von entzündlichen antworten
US6022853A (en) 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
SE469653B (sv) 1992-01-13 1993-08-16 Lucocer Ab Poroest implantat
CZ287715B6 (en) 1992-02-12 2001-01-17 Bioph Biotech Entw Pharm Gmbh DNA sequence, recombinant DNA molecule containing thereof, process for preparing protein from the group of TGF-beta substances, pharmaceutical preparation containing such protein, antibody or fragment thereof and its use
US6120760A (en) 1992-02-12 2000-09-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Growth/differentiation factors of the TGF-β family
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
AU667877B2 (en) 1992-02-14 1996-04-18 Board Of Regents, The University Of Texas System Multi-phase bioerodible implant/carrier and method of manufacturing and using same
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5610021A (en) * 1992-02-21 1997-03-11 Creative Biomolecules, Inc. Compositions and methods for identification and use of soluble complex forms of osteogenic proteins
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
US5397235A (en) 1993-07-02 1995-03-14 Dental Marketing Specialists, Inc. Method for installation of dental implant
EP1439190A1 (en) 1993-01-12 2004-07-21 The Johns Hopkins University School Of Medicine Growth differentiation factor-5
CA2151486A1 (en) 1993-01-12 1994-07-21 Arthur J. Ammann Tgf-beta formulation for inducing bone growth
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
EP0733109B9 (en) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 and tendon-inducing compositions thereof
US6027919A (en) 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
US5681746A (en) 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
WO1996026737A1 (en) 1995-03-01 1996-09-06 Creative Biomolecules, Inc. Morphogen-induced dentine regeneration
US5782919A (en) * 1995-03-27 1998-07-21 Sdgi Holdings, Inc. Interbody fusion device and method for restoration of normal spinal anatomy
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6541037B1 (en) 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US6117456A (en) 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
ES2440441T3 (es) 1995-06-05 2014-01-29 Genetics Institute, Llc Uso de proteínas morfogenéticas óseas para cicatrización y reparación de uniones de tejido conjuntivo
ES2225870T3 (es) * 1996-02-29 2005-03-16 Bioactive Bone Substitute Oy, Ab Dispositivo osteogenico y su procedimiento de preparacion.
US6143948A (en) 1996-05-10 2000-11-07 Isotis B.V. Device for incorporation and release of biologically active agents
EP0806211B1 (en) 1996-05-10 2002-10-23 IsoTis N.V. Implant material and process for producing it
EP0806212B1 (en) † 1996-05-10 2003-04-02 IsoTis N.V. Device for incorporation and release of biologically active agents
US6069295A (en) 1996-05-10 2000-05-30 Isotis B.V. Implant material
US6953594B2 (en) 1996-10-10 2005-10-11 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
CA2270185C (en) 1996-10-16 2009-01-06 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
DE19647853A1 (de) 1996-11-19 1998-05-20 Bioph Biotech Entw Pharm Gmbh Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
US20020082224A1 (en) 1997-01-14 2002-06-27 Douglas J. Jolly Non-immunogenic prodrugs and selectable markers for use in gene therapy
IL130967A0 (en) 1997-01-30 2001-01-28 Hoechst Marion Roussel Ltd Freeze-dried composition of bone morphogenetic protein human mp52
US6281195B1 (en) 1997-02-07 2001-08-28 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US20020098222A1 (en) 1997-03-13 2002-07-25 John F. Wironen Bone paste
US20030032586A1 (en) † 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
US6129928A (en) 1997-09-05 2000-10-10 Icet, Inc. Biomimetic calcium phosphate implant coatings and methods for making the same
EP1017797B1 (en) 1997-09-24 2005-06-22 The Regents Of The University Of California Non-primate lentiviral vectors and packaging systems
US20020048805A1 (en) 1998-01-16 2002-04-25 Julie C. Johnston Feline immunodeficiency virus gene therapy vectors
CA2318575A1 (en) 1998-01-16 1999-07-22 Chiron Corporation Feline immunodeficiency virus gene therapy vectors
US6365150B1 (en) 1998-05-13 2002-04-02 Genetix Pharmaceuticals, Inc. Lentiviral packaging cells
US6261322B1 (en) 1998-05-14 2001-07-17 Hayes Medical, Inc. Implant with composite coating
KR100298178B1 (ko) 1998-06-29 2001-08-07 박종섭 이미지센서의포토다이오드
US6328765B1 (en) 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6423544B1 (en) 1998-12-31 2002-07-23 Chiron Corporation Compositions and methods for producing recombinant virions
ATE253385T1 (de) 1999-02-04 2003-11-15 Sdgi Holdings Inc Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung
ES2242600T3 (es) 1999-02-04 2005-11-16 Sdgi Holdings, Inc. Composiciones de pasta osteogenica y sus usos.
US6730297B1 (en) 1999-05-28 2004-05-04 Chiron Corporation Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
SE515695C2 (sv) 1999-05-31 2001-09-24 Nobel Biocare Ab Implantat med beläggning av bentillväxtstimulerande substans för applicering i ben och förfarande vid sådant implantat
SE514323C2 (sv) 1999-05-31 2001-02-12 Nobel Biocare Ab Implantat samt förfarande och användning vid implantat
SE514202C2 (sv) 1999-05-31 2001-01-22 Nobel Biocare Ab På implantat till ben- eller vävnadsstruktur anordnat skikt samt sådant implantat och förfarande för applicering av skiktet
MXPA02000937A (es) * 1999-07-28 2002-07-30 Regeneration Tech Inc Implantes de tejidos con antigenicidad reducida (tar).
US6696410B1 (en) * 1999-09-27 2004-02-24 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
WO2001028602A1 (en) 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
JP2003512097A (ja) 1999-10-15 2003-04-02 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 骨形成蛋白のデリバリーのための処方
DE19950386A1 (de) 1999-10-19 2001-05-10 Miladin Lazarov Biokompatibler Gegenstand
CA2399216A1 (en) † 2000-02-04 2001-08-09 Isotis N.V. Proteinaceous coating
US20020022885A1 (en) * 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
US20020037281A1 (en) 2000-05-26 2002-03-28 Davidson Beverly L. Methods of transducing neural cells using lentivirus vectors
US6533821B1 (en) 2000-06-22 2003-03-18 Thomas Lally Bio-adhesive composition, method for adhering objects to bone
US7419829B2 (en) 2000-10-06 2008-09-02 Oxford Biomedica (Uk) Limited Vector system
US20030003565A1 (en) 2000-11-27 2003-01-02 Dubensky Thomas W. Functional lentiviral vector from an MLV-based backbone
US20020082679A1 (en) * 2000-12-22 2002-06-27 Avantec Vascular Corporation Delivery or therapeutic capable agents
CA2433657A1 (en) 2001-01-05 2002-07-11 Duke University Contrast enhancement agent for magnetic resonance imaging
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US20030049328A1 (en) * 2001-03-02 2003-03-13 Dalal Paresh S. Porous beta-tricalcium phosphate granules and methods for producing same
EP1492475B1 (en) 2001-04-16 2011-12-21 Wright Medical Technology, Inc. Dense/porous structures for use as bone substitutes
ES2424614T3 (es) * 2001-05-01 2013-10-07 Amedica Corporation Injerto óseo radiolúcido
US20030039636A1 (en) 2001-05-01 2003-02-27 Genetix Pharmaceuticals, Inc. Novel self-inactivating (SIN) lentiviral vectors
SE519564C2 (sv) 2001-07-04 2003-03-11 Nobel Biocare Ab Implantat, t ex dentalt implantat, belagt med bentillväxtstimulerande medel
SE519566C2 (sv) 2001-07-04 2003-03-11 Nobel Biocare Ab Förfarande för behandling av implantat genom beläggning med kalciumfosfat och bentillväxtstimulerande medel

Also Published As

Publication number Publication date
DE60205937T3 (de) 2016-01-21
AU2002308204B2 (en) 2007-09-27
CN1561235A (zh) 2005-01-05
SI1448246T2 (sl) 2015-12-31
DK1448246T3 (da) 2005-12-27
EP1448246A1 (en) 2004-08-25
DE60205937D1 (de) 2005-10-06
JP5054091B2 (ja) 2012-10-24
CA2466947A1 (en) 2003-05-30
JP2010075737A (ja) 2010-04-08
JP4473576B2 (ja) 2010-06-02
JP2005509494A (ja) 2005-04-14
CN100425285C (zh) 2008-10-15
US8546334B2 (en) 2013-10-01
HK1071315A1 (en) 2005-07-15
ES2247423T3 (es) 2006-03-01
DK1448246T4 (en) 2015-12-21
US20150080303A1 (en) 2015-03-19
WO2003043673A1 (en) 2003-05-30
EP1448246B2 (en) 2015-09-09
AU2002308204B9 (en) 2008-06-12
US20060088565A1 (en) 2006-04-27
BR0214275A (pt) 2004-09-21
CY1105664T1 (el) 2010-12-22
SI1448246T1 (sl) 2005-12-31
ES2247423T5 (es) 2015-12-30
AU2002308204A1 (en) 2003-06-10
DE60205937T2 (de) 2006-06-14
EP1448246B1 (en) 2005-08-31
ATE303169T1 (de) 2005-09-15
CA2466947C (en) 2012-05-22

Similar Documents

Publication Publication Date Title
HK1071315A1 (en) Device having osteoinductive and osteoconductive properties
HUP0401357A2 (hu) Kalcium-foszfát hordozóanyagok csontképződést serkentő fehérjék bejuttatásához
Hing et al. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds
Bayani et al. Main properties of nanocrystalline hydroxyapatite as a bone graft material in treatment of periodontal defects. A review of literature
Hu et al. Cerium-doped whitlockite nanohybrid scaffolds promote new bone regeneration via SMAD signaling pathway
Cabrejos-Azama et al. Magnesium substitution in brushite cements for enhanced bone tissue regeneration
Jungbluth et al. Platelet‐rich plasma on calcium phosphate granules promotes metaphyseal bone healing in mini‐pigs
Zhang et al. New bone formation in a true bone ceramic scaffold loaded with desferrioxamine in the treatment of segmental bone defect: a preliminary study
Moghanian et al. Synthesis and characterization of osteoinductive visible light‐activated adhesive composites with antimicrobial properties
BRPI0516105B8 (pt) material de implante consistindo em fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso, material de implante consistindo em aloenxerto ou colágeno e aloenxerto, método de preparação dos mesmos, uso de fosfato de cálcio poroso ou colágeno e fosfato de cálcio poroso na preparação do referido material de implante e uso de aloenxerto ou colágeno e aloenxerto na preparação do referido material de implante
ES2136668T3 (es) Fosfato calcico como precursor de la hidroxiapatita y procedimiento para su preparacion y utilizacion.
JP2011500299A (ja) 成長因子の充填された粒子を製造する方法ならびにかくして得られた粒子
Vater et al. Modifications of a calcium phosphate cement with biomolecules—Influence on nanostructure, material, and biological properties
Tang et al. Enhancement of local bone formation on titanium implants in osteoporotic rats by biomimetic multilayered structures containing parathyroid hormone (PTH)-related protein
Dewi et al. Behavior of plaster of Paris‐calcium carbonate composite as bone substitute. A study in rats
Stanić Boron-containing bioactive glasses for bone regeneration
Chang et al. The effects of injectable calcium silicate-based composites with the Chinese herb on an osteogenic accelerator in vitro
Kumar et al. Quantitative assessment of degradation, cytocompatibility, and in vivo bone regeneration of silicon-incorporated magnesium phosphate bioceramics
Iviglia et al. New collagen‐coated calcium phosphate synthetic bone filler (Synergoss®): A comparative surface analysis
He et al. Osteogenesis-inducing calcium phosphate nanoparticle precursors applied to titanium surfaces
PT1539261E (pt) Implante metalico revestido sob concentracao reduzida de oxigenio com proteina osteoindutiva
Yang et al. Osteoblast response to puerarin‐loaded porous titanium surfaces: An in vitro study
Parisi et al. Aptamers recognizing fibronectin confer improved bioactivity to biomaterials and promote new bone formation in a periodontal defect in rats
Bosco et al. Configurational effects of collagen/ALP coatings on enzyme immobilization and surface mineralization
Jo et al. Cell recognitive bioadhesive‐based osteogenic barrier coating with localized delivery of bone morphogenetic protein‐2 for accelerated guided bone regeneration